Loading...
Market
Outcome of Taiwan's WHA77 observer bid
4
United States•Taiwan•World Health Assembly•Geneva•Antony Blinken•World Health Organization•WHO•Senate•China
Resolution / Starting Odds
Accepted as observer • 33%
Rejected due to opposition • 33%
Deferred decision • 34%
Official WHO announcements and international media coverage
Story
U.S. Backs Taiwan's WHA77 Observer Bid Amid China's Opposition
May 2, 2024, 03:50 AM
The United States has expressed strong support for Taiwan's participation as an observer at the upcoming World Health Assembly (WHA77) in Geneva. U.S. Secretary of State Antony Blinken publicly urged the World Health Organization (WHO) to reinstate Taiwan's invitation to the assembly during a Senate subcommittee hearing, emphasizing the value of Taiwan's contributions to global health challenges. Despite U.S. advocacy, Taiwan's attendance remains uncertain due to political opposition from China, which has expressed strong dissatisfaction with the U.S. stance, citing its political agenda. China's resistance highlights the geopolitical tension surrounding Taiwan's international participation and recognition.
View original story
Similar markets
Support Taiwan's inclusion • 33%
Uphold China's stance • 33%
Remain neutral • 34%
Supportive • 33%
Neutral • 33%
Opposed • 34%
Accepted • 33%
Rejected • 33%
No Response • 34%
USA • 25%
UK • 25%
Germany • 25%
None • 25%
Treaty unchanged • 33%
Minor amendments • 33%
Major overhaul or withdrawal • 33%
Approve • 33%
Reject • 33%
Neutral/Abstain • 33%
Broad international support for China • 25%
Mixed international reaction • 25%
Broad international support for Taiwan • 25%
No significant international response • 25%